BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding receipt of In ��� Principle approval from the Stock……
| Subscribe To Our Free Newsletter |
